These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19157735)

  • 1. Oxethazaine as the source of mephentermine and phentermine in athlete's urine.
    Hsu MC; Lin SF; Kuan CP; Chu WL; Chan KH; Chang-Chien GP
    Forensic Sci Int; 2009 Mar; 185(1-3):e1-5. PubMed ID: 19157735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis.
    Huang WH; Liu CH; Liu RH; Tseng YL
    J Anal Toxicol; 2010 Mar; 34(2):73-7. PubMed ID: 20223098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of phentermine, N-hydroxyphentermine and mephentermine in urine using dilute and shoot liquid chromatography-tandem mass spectrometry.
    Choi YJ; Sim A; Kim MK; Suh S; In MK; Kim JY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():22-27. PubMed ID: 27398632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Famprofazone as the source of methamphetamine and amphetamine in urine specimen collected during sport competition.
    Tseng YL; Lin CT; Wang SM; Liu RH
    J Forensic Sci; 2007 Mar; 52(2):479-86. PubMed ID: 17316255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The abuse potential of oxethazaine: effects of oxethazaine on drug-seeking behavior and analysis of its metabolites in plasma and hair in animal models.
    Lee SY; You IJ; Kim MJ; Kwon SH; Hong SI; Kim JH; Jang MH; Oh SM; Chung KH; Lee SY; Jang CG
    Pharmacol Biochem Behav; 2013 Apr; 105():98-104. PubMed ID: 23402942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of urinary p-hydroxylated metabolites of mephentermine and phentermine in male Wistar rats.
    Mori MA; Uy-Yu N; Sakai K; Inoue M; Miyahara T; Kozuka H
    Xenobiotica; 1990 Jul; 20(7):653-6. PubMed ID: 2238700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel analysis of stimulants in saliva and urine by gas chromatography/mass spectrometry: perspectives for "in competition" anti-doping analysis.
    Strano-Rossi S; Colamonici C; Botrè F
    Anal Chim Acta; 2008 Jan; 606(2):217-22. PubMed ID: 18082653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
    Van Thuyne W; Delbeke FT
    Int J Sports Med; 2006 Sep; 27(9):745-50. PubMed ID: 16586337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Adrenergic stimulation.
    Van Eenoo P; Delbeke FT
    Handb Exp Pharmacol; 2010; (195):227-49. PubMed ID: 20020368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of gas chromatography combined with simultaneously selected ion monitoring and full scan mass spectrometry in doping analysis.
    Van Thuyne W; Van Eenoo P; Delbeke FT
    J Chromatogr A; 2008 Nov; 1210(2):193-202. PubMed ID: 18849031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection in urine of 4-methyl-2-hexaneamine, a doping agent.
    Perrenoud L; Saugy M; Saudan C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3767-70. PubMed ID: 19800302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive screening method for the qualitative detection of narcotics and stimulants using single step derivatisation.
    Van Thuyne W; Van Eenoo P; Delbeke FT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):259-65. PubMed ID: 17715003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone abuse in sports: the antidoping perspective.
    Barroso O; Mazzoni I; Rabin O
    Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolism and urinary excretion in man of phentermine, and the influence of N-methyl and p-chloro-substitution.
    Beckett AH; Brookes LG
    J Pharm Pharmacol; 1971 Apr; 23(4):288-94. PubMed ID: 4396907
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of seven Oxethazaine containing antacids available in the Indian market.
    Bhoir S; Bhagwat AM
    J Assoc Physicians India; 2013 Jun; 61(6):400-3. PubMed ID: 24640206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
    Badoud F; Grata E; Perrenoud L; Avois L; Saugy M; Rudaz S; Veuthey JL
    J Chromatogr A; 2009 May; 1216(20):4423-33. PubMed ID: 19342059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of mephentermine in male guinea pigs and male mice.
    Mori MA; Kobayashi M; Yumoto Y; Nakafuku K; Miyahara T; Kozuka H
    Xenobiotica; 1991 Oct; 21(10):1301-9. PubMed ID: 1796607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of caffeine use in elite athletes following its removal from the World Anti-Doping Agency list of banned substances.
    Del Coso J; Muñoz G; Muñoz-Guerra J
    Appl Physiol Nutr Metab; 2011 Aug; 36(4):555-61. PubMed ID: 21854160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of diuretics on the excretion and metabolism of doping agents. II. Phentermine.
    Delbeke FT; Debackere M
    Arzneimittelforschung; 1986; 36(1):134-7. PubMed ID: 3954816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doping control analysis for adrafinil and its major metabolites in human urine.
    Lu J; Wang X; Yang S; Liu X; Qin Y; Shen L; Wu Y; Xu Y; Wu M; Ouyang G
    Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1592-600. PubMed ID: 19399790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.